immunomeinc
Immunome is seeking an experienced Senior/Principal Scientist to lead ADC conjugation process development, optimizing conjugation and purification parameters from milligram to multi‑gram scales for clinical and commercial drug substance manufacturing. The role involves technology transfer, GMP coordination with CDMOs, and supporting regulatory submissions for IND and BLA activities.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for immunomeinc.
30% above the average for this role
Senior Engineer, ADC Manufacturing
lottebiologicsusallc.com
Bench Scientist
Real Staffing
Post-Doctoral Scientist, Bioconjugation Process Innovation
Eli Lilly and Company
Scientist II, Conjugation Development
Vaxcyte
Senior Principal Scientist (Antibody Drug Conjugate)
Exelixis
Senior Scientist, Protein and Antibody Bioconjugation
lifelancer